Greenwich LifeSciences (GLSI) Treasury Shares (2022 - 2023)

Greenwich LifeSciences' (GLSI) quarterly Treasury Shares came in at $519828.0 in Q4 2023, little changed on a QoQ basis from $519828.0 in Q3 2023.

Analysis

Greenwich LifeSciences (GLSI) Treasury Shares (2022 - 2023) Analysis & Trends

Greenwich LifeSciences (GLSI) has 2 years of Treasury Shares data on file, last reported at $519828.0 in Q4 2023.

Quarterly Treasury Shares changed N/A year-over-year to $519828.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $519828.0 (changed N/A YoY) and the FY2023 annual result came in at $519828.0, changed N/A from the prior year.
Treasury Shares was little changed at $519828.0 in Q4 2023, from $519828.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $519828.0 in Q2 2022 to a low of $269828.0 in Q1 2022.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	2.72 Mn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Greenwich LifeSciences	231.59 Mn	231.59 Mn	-	-

Historic Data

Download Data